HomePVLA • NASDAQ
add
Palvella Therapeutics Inc
Previous close
$13.00
Day range
$12.02 - $13.22
Year range
$6.20 - $22.32
Market cap
107.95M USD
Avg Volume
33.65K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.06M | 225.95% |
Net income | -6.78M | -139.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.21M | — |
Total assets | 16.32M | — |
Total liabilities | 33.12M | — |
Total equity | -16.80M | — |
Shares outstanding | 5.72M | — |
Price to book | -0.85 | — |
Return on assets | -79.93% | — |
Return on capital | -149.99% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.78M | -139.23% |
Cash from operations | -2.74M | 12.06% |
Cash from investing | — | — |
Cash from financing | 2.41M | — |
Net change in cash | -330.00K | 89.42% |
Free cash flow | -1.80M | — |
About
Founded
2015
Website
Employees
7
